tiprankstipranks
GT Biopharma (GTBP)
NASDAQ:GTBP
Holding GTBP?
Track your performance easily

GT Biopharma (GTBP) Financial Statements

219 Followers

GT Biopharma Financial Overview

GT Biopharma's market cap is currently ―. The company's EPS TTM is $-7.48; its P/E ratio is -0.41; GT Biopharma is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.41M$ -3.71M$ 2.27M$ -2.96M$ -1.99M
EBITDA$ -3.41M$ -3.68M$ 2.29M$ -2.96M$ -1.97M
Net Income Common Stockholders$ -3.41M$ -3.71M$ -2.30M$ -2.96M$ -1.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.42M$ 9.25M$ 9.85M$ 13.98M$ 17.97M
Total Assets$ 6.76M$ 9.27M$ 9.91M$ 14.11M$ 18.14M
Total Debt$ 0.00$ 0.00$ 30.00K$ 58.00K$ 120.00K
Net Debt$ -6.42M$ -9.25M$ -9.82M$ -13.92M$ -17.85M
Total Liabilities$ 4.66M$ 3.76M$ 4.60M$ 6.63M$ 6.38M
Stockholders Equity$ 2.10M$ 5.50M$ 5.30M$ 7.48M$ 11.80M
Cash Flow-
Free Cash Flow$ -2.70M$ -3.50M$ -4.20M$ -2.05M$ -1.94M
Operating Cash Flow$ -2.70M$ -3.50M$ -4.20M$ -2.05M$ -1.94M
Investing Cash Flow$ -1.00K$ 7.86M$ 5.03M$ 478.00K$ 2.66M
Financing Cash Flow-$ 2.98M---
Currency in USD

GT Biopharma Earnings and Revenue History

GT Biopharma Debt to Assets

GT Biopharma Cash Flow

GT Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis